Other substances

Antihistamines

Phase of research

Potential treatment - clinical evidence

How it helps

Other treatment

Drug status

Used to treat other disease

1
 Supporting references
0
 Contradictory references
6
 AI-suggested references
0
 Clinical trials

General information

Antihistamines are drugs targeting histamine receptors. There are 4 types of histamine receptors (H1-4), differing in their distribution and response they facilitate. Antihistamines targeting H1 receptors are well-known for their anti-allergic and anti-inflammatory properties. H2 antihistamines are used for gastric acid production-related disorders; however, nowadays they are often not the drugs of first choice. H3 antihistamines are being developed for the treatment of cognitive disorders and H4 antihistamines could have benefit for patients with immune and inflammatory disorders (Mahdy and Webster, 2011).

Antihistamines on Wikipedia

 

Supporting references

Link Tested on Impact factor Notes Publication date
Antihistamines and azithromycin as a treatment for COVID-19 on primary health care – A retrospective observational study in elderly patients
Elderly Small molecule Cohort study 		Elderly patients 2.68

In combination with <a href=

 Jan/16/2021

AI-suggested references

Link Publication date
Antihistamine and cationic amphiphilic drugs, old molecules as new tools against the COVID-19?
Jan/24/2021
The effect of COVID-19 on patients with chronic spontaneous urticaria treated with omalizumab and antihistamines: A cross-sectional, comparative study
Mar/25/2022
Combinational benefit of antihistamines and remdesivir for reducing SARS-CoV-2 replication and alleviating inflammation-induced lung injury in mice
Jul/08/2021
Antihistamines and azithromycin as a treatment for COVID-19 on primary health care - A retrospective observational study in elderly patients
Jan/16/2021
Identification of antiviral antihistamines for COVID-19 repurposing.
Dec/03/2020
Successful Desensitization to mRNA COVID-19 Vaccine in a Case Series of Patients With a History of Anaphylaxis to the First Vaccine Dose
Feb/02/2022
Export (.csv)